佐匹克隆
參考資料

医学主题
↑  . Drug Ther Bull. December 2004, 42 (12): 89–93. PMID 15587763. doi:10.1136/dtb.2004.421289.
↑  Touitou Y. . Ann Pharm Fr. July 2007, 65 (4): 230–8. PMID 17652991 （法语）.
↑  Gorenstein C, Tavares SM, Gentil V, Peres C, Moreno RA, Dreyfus JF. . Braz. J. Med. Biol. Res. 1990, 23 (10): 941–51. PMID 2101059.
↑  Gustavsen I, Bramness JG, Skurtveit S, Engeland A, Neutel I, Mørland J. . Sleep Med. December 2008, 9 (8): 818–22  [2014-08-27]. PMID 18226959. doi:10.1016/j.sleep.2007.11.011. （原始内容存档于2018-08-18）.
↑  Verster JC, Veldhuijzen DS, Patat A, Olivier B, Volkerts ER. . Curr Drug Saf. January 2006, 1 (1): 63–71. PMID 18690916. doi:10.2174/157488606775252674.
↑  Vermeeren A, Riedel WJ, van Boxtel MP, Darwish M, Paty I, Patat A. . Sleep. March 2002, 25 (2): 224–31. PMID 11905433.
↑  Fontaine, R; Beaudry, P; Le, Morvan, P; Beauclair, L; Chouinard, G. . International clinical psychopharmacology (PDF)使用|format=需要含有|url= (帮助). Jul 1990, 5 (3): 173–183. ISSN 0268-1315. PMID 2230061. doi:10.1097/00004850-199007000-00002.
↑  Giercksky, Ke; Wickstrom, E. . Clinical therapeutics. 1980, 3 (1): 21–7. ISSN 0149-2918. PMID 6996815.
↑  Ratrema M; Guy C; Nelva A;  et al. . Therapie. 2001, 56 (1): 41–50. PMID 11322016 （法语）.
↑  Nicholson, An; Stone, Bm. . International pharmacopsychiatry. 1982,. 17 Suppl 2: 92–7. ISSN 0020-8272. PMID 7188378.
↑  Subhan, Z; Hindmarch, I. . Neuropsychobiology. 1984, 12 (4): 244–8. ISSN 0302-282X. PMID 6152563. doi:10.1159/000118146.
↑  Channer, Ks; Dent, M; Roberts, Cj. . British Journal of Clinical Pharmacology. Dec 1984, 18 (6): 879–86. ISSN 0306-5251. PMC 1463687 . PMID 6529528. doi:10.1111/j.1365-2125.1984.tb02559.x.
↑  Monchesky, Tc; Billings, Bj; Phillips, R. . Clinical therapeutics. 1986, 8 (3): 283–91. ISSN 0149-2918. PMID 3521857.
↑  Bocca ML, Denise P. . J. Psychopharmacol. (Oxford). 2000, 14 (4): 401–5. PMID 11198059. doi:10.1177/026988110001400409.
↑  Moloney I, Breen EG, El Hassan H, Kelly BD. . Ir Med J. June 2007, 100 (6): 511. PMID 17668690.
↑  Ferentinos P, Paparrigopoulos T. . Int. J. Neuropsychopharmacol. February 2009, 12 (1): 141–2. PMID 18925983. doi:10.1017/S1461145708009541.
↑  Warot, D; Bensimon, G; Danjou, P; Puech, Aj. . Fundamental & clinical pharmacology. 1987, 1 (2): 145–52. ISSN 0767-3981. PMID 3679064. doi:10.1111/j.1472-8206.1987.tb00553.x.
↑  Fava GA. . Eur. J. Clin. Pharmacol. 1996, 50 (6): 509. PMID 8858280. doi:10.1007/s002280050149.
↑  Silva A, Collao A, Orellana M, Meléndez J, Caviedes P, Cárdenas AM. . Neurosci. Res. October 2003, 47 (2): 241–3  [2014-08-27]. PMID 14512149. doi:10.1016/S0168-0102(03)00170-6. （原始内容存档于2018-06-23）.
↑  David M, Breton JL, Guy I, Vandel S. . Therapie. 1998, 53 (1): 78–80. PMID 9773104 （法语）.
↑  Hussain N, MacKinnon M, Akbari A. . Am. J. Kidney Dis. May 2003, 41 (5): E17  [2014-08-27]. PMID 12778435. doi:10.1016/S0272-6386(03)00382-2. （原始内容存档于2020-09-24）.
↑  Bramness JG; Olsen H. . Tidsskrift for den Norske laegeforening. 1998, 118 (13): 2029–32. PMID 9656789.
↑  Luty S, Sellman D. . N. Z. Med. J. July 1993, 106 (959): 293. PMID 8321452.
↑  Deveaux M, Chèze M, Pépin G. . Ther Drug Monit. April 2008, 30 (2): 225–8  [2014-08-27]. PMID 18367985. doi:10.1097/FTD.0b013e3181676186. （原始内容存档于2013-06-01）.
↑  . Prescrire Int. February 2001, 10 (51): 15. PMID 11503851.
↑  Wong CP, Chiu PK, Chu LW.  (PDF). Age Ageing. September 2005, 34 (5): 526–7  [2014-08-27]. PMID 16107464. doi:10.1093/ageing/afi132. （原始内容存档于2006-03-02）.
↑  Jones IR, Sullivan G. . BMJ. January 1998, 316 (7125): 117. PMC 2665371 . PMID 9462317. doi:10.1136/bmj.316.7125.117.
↑  Aranko, K; Henriksson, M; Hublin, C; Seppäläinen, Am. . Pharmacopsychiatry. Jul 1991, 24 (4): 138–40. ISSN 0176-3679. PMID 1754610. doi:10.1055/s-2007-1014457.
↑  Anderson, Aa. . Sleep. 1987,. 10 Suppl 1: 54–62. ISSN 0161-8105. PMID 3326116.
↑  Mendelson WB, Jain B. . Drug Saf. October 1995, 13 (4): 257–70. PMID 8573298. doi:10.2165/00002018-199513040-00005.
↑  Harter C, Piffl-Boniolo E, Rave-Schwank M. . Psychiatr Prax. November 1999, 26 (6): 309. PMID 10627964 （德语）.
↑  sanofi-aventis Canada Inc.  (PDF). October 30, 2008  [2014-08-27]. （原始内容 (PDF)存档于2016-03-14）.
↑  Kahlert I; Brüne M. . Dtsch Med Wochenschr. June 2001, 126 (22): 653–4. PMID 11450624. doi:10.1055/s-2001-14488.
↑  Professor Heather Ashton. .   [2014-08-27]. （原始内容存档于2019-05-07）.
↑  Fontaine, R; Beaudry, P; Le, Morvan, P; Beauclair, L; Chouinard, G. . International clinical psychopharmacology (PDF)使用|format=需要含有|url= (帮助). Jul 1990, 5 (3): 173–83. ISSN 0268-1315. PMID 2230061. doi:10.1097/00004850-199007000-00002.
↑  WHO.  (PDF). who.int. 2006  [2014-08-27]. （原始内容存档 (PDF)于2015-01-31）.
↑  Kuitunen T; Mattila MJ; Seppala T. . Int Clin Psychopharmacol. April 1990, 5 (Suppl 2): 115–30. PMID 2201724.
↑  Parker, G; Roberts, Cj. . British Journal of Clinical Pharmacology. Sep 1983, 16 (3): 259–65. ISSN 0306-5251. PMC 1428012 . PMID 6626417. doi:10.1111/j.1365-2125.1983.tb02159.x.
↑  Tada, K; Sato, Y; Sakai, T; Ueda, N; Kasamo, K; Kojima, T. . Neuropsychobiology. 1994, 29 (1): 17–22. ISSN 0302-282X. PMID 8127419. doi:10.1159/000119057.
↑  Allain H, Bentué-Ferrer D, Tarral A, Gandon JM.  (PDF). Eur. J. Clin. Pharmacol. July 2003, 59 (3): 179–88  [2014-08-27]. PMID 12756510. doi:10.1007/s00228-003-0591-5. （原始内容 (PDF)存档于2020-03-28）.
↑  Antai-Otong D. . Perspect Psychiatr Care. August 2006, 42 (3): 196–200  [2014-08-27]. PMID 16916422. doi:10.1111/j.1744-6163.2006.00070.x. （原始内容存档于2020-03-28）.
↑  Upfal, Jonathan.  5. Melbourne: Bookman Press Pty Ltd. 2000: 743 [1991]. ISBN 1-86395-170-9.
↑  Cimolai N. . Can Fam Physician. December 2007, 53 (12): 2124–9. PMC 2231551 . PMID 18077750.
↑  Griffiths RR, Johnson MW. . J Clin Psychiatry. 2005,. 66 Suppl 9: 31–41. PMID 16336040.
↑  Hoffmann F, Pfannkuche M, Glaeske G. . Nervenarzt. January 2008, 79 (1): 67–72. PMID 17457554. doi:10.1007/s00115-007-2280-6 （德语）.
↑  Ströhle A, Antonijevic IA, Steiger A, Sonntag A. . Nervenarzt. January 1999, 70 (1): 72–5. PMID 10087521. doi:10.1007/s001150050403 （德语）.
↑  Kratzsch C, Tenberken O, Peters FT et al. Screening, library-assisted identification, and validated quantification of 23 benzodiazepines, flumazenil, zaleplone, zolpidem, and zopiclone in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization. J. Mass Spec. 39: 856-872, 2004.
↑  Gustavsen I, Al-Sammurraie M, Mørland J, Bramness JG. Impairment related to blood drug concentrations of zopiclone and zolpidem compared with alcohol in apprehended drivers. Accid. Anal. Prev. 41: 462-466, 2009.
↑  R. Baselt, Disposition of Toxic Drugs and Chemicals in Man, 8th edition, Biomedical Publications, Foster City, CA, 2008, pp. 1677-1679.